Introduction {#S1}
============

CtBP was originally identified based on its ability to bind the carboxyl terminus of the E1A oncoprotein ([@R2]; [@R31]). Subsequently, CtBP was found as a transcriptional co-repressor involved in a variety of biological processes including proliferation and anti-apoptosis ([@R4]). CtBP indirectly binds DNA with various DNA binding partners at multiple DNA sequences thus CtBP-mediated transcriptional repression is context-specific. For instance, CtBP represses *E-cadherin* in epithelial cells ([@R9]; [@R10]; [@R38]), *IL-4* in human T cells ([@R20]), and *dll4*, *sprouty*, and *ve-cadherin* for endothelial sprouting ([@R29]). Recently, we and others found that CtBP down-regulates DNA damage repair by directly suppressing the transcription of *breast cancer type 1 susceptibility protein* (*Brca1*) in cancer cells ([@R5]; [@R6]).

In mammals, there are two isoforms, CtBP1 and CtBP2. Both isoforms are expressed in the wildtype mouse embryo and play overlapping and unique roles ([@R15]). CtBP1 knockout mice are small and 23% die of an unknown cause by 20 days postpartum. CtBP2-null mice are small in size, have axial truncations, delayed neural, muscular and skeletal development, and defects in heart morphogenesis; they die by E10.5 due to defects in both yolk sac and placental vascularization. In most human and mouse adult tissues, CtBP expression is low. Re-activation of CtBP expression has been shown in pathological conditions, *e.g*, cancer ([@R5]; [@R26]), but its *in vivo* role in adult tissue is virtually unknown.

To determine the effects of aberrant CtBP1 expression in keratinocytes *in vivo*, we targeted CtBP1 over-expression to the basal layer of the epidermis and hair follicle using a keratin 5 promoter (K5.CtBP1) ([@R14]). K5.CtBP1-transgenic epidermis displayed loss of E-cadherin, hyperproliferation and decreased differentiation. Unexpectedly, K5.CtBP1 mice also exhibited defective hair morphogenesis starting at the postnatal stage. Molecular analyses revealed that CtBP1 directly repressed transcription of the *Dlx3* gene, a homeobox transcription factor that plays a critical role in hair development by orchestrating the differentiation of the inner root sheath and hair shaft ([@R16]). Supporting this link, we found a hair follicle formation defect in the K5.CtBP1 mice, with decreased expression of *Dlx3* and its target genes. Our study provides *in vivo* model for CtBP1 over-expression and reveals that CtBP1 over-expression perturbs epidermal and hair follicle homeostasis.

Results {#S2}
=======

Generation of the CtBP1 transgenic mice {#S3}
---------------------------------------

In normal mouse skin, CtBP1 is barely detectable. Acute skin wound by punch biopsy induced CtBP1 expression \~6 fold higher than in non-wounded skin ([Fig. 1A](#F1){ref-type="fig"}). To evaluate the role of CtBP1 over-expression in the skin, we generated K5.CtBP1 transgenic mice by inserting human CtBP1 cDNA (99% amino acid homology to mouse CtBP1 protein) into a K5 vector ([@R14]). Three K5.CtBP1 transgenic founders (K1, K2, and K3) were generated. Their CtBP1 transgene expression levels were 7--10 fold higher than endogenous CtBP1, but comparable to wounds at the mRNA level ([Fig. 1A](#F1){ref-type="fig"}). Overall, K5.CtBP1 phenotype severity correlated with transgene expression levels, suggesting CtBP1 over-expression causes the phenotype. Results from the representative line K2 were shown in this study. K5.CtBP1 pups were born without gross abnormality (not shown), but began to exhibit thickened skin at 1 week postpartum when wildtype mice developed their first coat of hair and K5.CtBP1 pups had no hair growth ([Fig. 1B](#F1){ref-type="fig"}). After weaning, K5.CtBP1 mice exhibited hair loss, on their dorsal and ventricle sides ([Fig. 1C](#F1){ref-type="fig"}). These transgenic mice died between 3 to 6 weeks of age due to severe hyperplasia in the esophagus ([Fig. 1D](#F1){ref-type="fig"}) and forestomach (not shown) where CtBP1 transgene was also expressed, compromising food intake. Compared to the wildtype control, these K5.CtBP1 mice also displayed abnormal epithelium in their tongues ([Fig. 1D](#F1){ref-type="fig"}).

K5.CtBP1 mice displayed epidermal hyperproliferation, with decreased expression of p21 and Brca1 {#S4}
------------------------------------------------------------------------------------------------

Re-activation of CtBP1 expression has been shown in cancer ([@R5]; [@R26]) and during wound healing ([Fig. 1A](#F1){ref-type="fig"}), presumably contributing to the hyper-proliferative process in these conditions. We biopsied the K5.CtBP1 skin at day 21 postpartum to examine morphology changes ([Fig. 2A](#F2){ref-type="fig"}) and expression of CtBP1 ([Fig. 2B and 2C](#F2){ref-type="fig"}). Hyperplasia in the epidermis of transgenic mice became obvious at the microscopic level ([Fig. 2A](#F2){ref-type="fig"}). Although the K5 promoter targets CtBP1 expression to basal keratinocytes, nuclear CtBP1 staining was apparent throughout the entire epidermis and hair follicles in K5.CtBP1 transgenic mice ([Fig. 2C](#F2){ref-type="fig"}), possibly due to protein retention in differentiated layers. In contrast, weak CtBP1 staining was detected in wildtype skin ([Fig. 2B and 2C](#F2){ref-type="fig"}). Interestingly, although CtBP1 transgene is targeted to keratinocytes, CtBP1-positive cells were also observed in the K5.CtBP1 dermis but not in wildtype dermis ([Fig. 2C](#F2){ref-type="fig"}). This is likely increased endogenous CtBP1 in stromal cells in response to changes in the epidermis and hair follicles. The origin of the cells over-expressing endogenous CtBP1 in the transgenic dermis remains to be determined.

*In vitro* studies show that CtBP1 has both anti-apoptotic and proliferative effects ([@R9]; [@R25]), potentially causing epidermal hyperplasia. Apoptosis, as determined by cleaved Caspase-3, was not changed in K5.CtBP1 skin (not shown). Proliferative cells, identified by PCNA staining, were sporadic in the basal layer of the epidermis and hair follicles of wildtype skin, but were expanded to suprabasal layers of K5.CtBP1 transgenic epidermis and hair follicles ([Fig. 2D](#F2){ref-type="fig"}). Furthermore, we found mRNA levels of *p21* and *Brca1* were decreased in skin with CtBP1 over-expression, with 5- and 11-fold reduction in the K5.CtBP1 skin compared to that of the control skin ([Fig. 2E and 2F](#F2){ref-type="fig"}), supporting the notion that CtBP1 positively contributes to proliferation in keratinocytes. We cultured keratinocytes from K5.CtBP1 mice. Consistent with the hyperplasic phenotype observed in the K5.CtBP1 mice, keratinocytes derived from these animals displayed a higher BrdU index than wildtype controls ([Fig. 2G](#F2){ref-type="fig"}), suggesting that the proliferative property is cell autonomous. No major difference was detected in the cell cycle analysis and migration assay (not shown).

CtBP1 transgene expression reduced differentiation and caused loss of E-cadherin in the epidermis and hair follicles {#S5}
--------------------------------------------------------------------------------------------------------------------

Previously, we and others demonstrated that CtBP1 represses the transcription of *E-cadherin* by directly targeting the *E-cadherin* promoter ([@R9]; [@R10]; [@R38]). To determine if CtBP1 expression in epithelial cells leads to *E-cadherin* reduction, we performed qRT-PCR on the K5.CtBP1 skin at day 21 postpartum and found that *E-cadherin* mRNA was decreased compared to wildtype control littermates ([Fig. 3A](#F3){ref-type="fig"}). Consistent with the mRNA decrease, E-cadherin protein was largely lost in K5.CtBP1 epidermis and hair follicles as seen by immunostaining ([Fig. 3B](#F3){ref-type="fig"}). The E-cadherin loss in K5.CtBP1 mice is progressive, as only a small decrease of E-cadherin was detected in day one pup skin compared to wildtype littermates (not shown).

Next, we examined the epidermal differentiation of K5.CtBP1 mice. Early epidermal differentiation markers, keratins K1 and K10, were not altered (not shown), but epidermal terminal differentiation markers loricrin and filaggrin were largely diminished by immunostaining in the K5.CtBP1 epidermis ([Fig. 3C](#F3){ref-type="fig"}) and significantly reduced by western blotting ([Fig. 3D](#F3){ref-type="fig"}). Because CtBP1 is a classic transcriptional co-repressor and potentially contributes to the decreased differentiation by transcriptional repression of the terminal differentiation players, we assayed the mRNA levels of *loricrin* and *filaggrin*, important physical barrier components in the epidermis against the environment ([@R3]; [@R18]). Different from the protein loss observed in the K5.CtBP1 epidermis, neither *loricrin* nor *filaggrin* showed a decrease in their mRNA levels ([Fig. 3E](#F3){ref-type="fig"}), suggesting the defect in epidermal terminal differentiation is a secondary effect.

CtBP1 transgene suppressed Dlx3, a critical regulator of hair follicle differentiation {#S6}
--------------------------------------------------------------------------------------

We biopsied neonatal skin and found no obvious hair follicle changes at birth (not shown), suggesting that CtBP1 did not affect hair development. Consistently, similar expression of LEF-1, β-catenin, and pSmad1/5/8 were detected in the CtBP1 transgenic skin hair follicles (not shown), implying that Wnt and BMP signaling pathways are not affected by CtBP1 over-expression in the epidermis. Structural hair follicle abnormalities were observed by day 9 postpartum. Hair follicles had formed large hair bulbs and differentiated hair shafts in wildtype mice. In contrast, CtBP1 transgenic hair follicles displayed smaller hair bulbs, with reduced keratinized medulla and defects in the inner root sheath and hair shaft ([Fig. 4A](#F4){ref-type="fig"}), phenotypes reminiscent of hair follicle abnormities observed in the Dlx3-null mice ([@R16]). Therefore, we used the Dlx3 hair follicle differentiation marker to explore the molecular mechanism associated with hair loss in K5.CtBP1 mice. At day 9 postpartum, Dlx3 was expressed in hair matrix cells, inner root sheath, as well as in hair-forming compartments such as the cortex, medulla and cuticle in hair follicles from the wildtype mice ([Fig. 4B](#F4){ref-type="fig"}, left panel). However, expression of Dlx3 was largely reduced in hair follicles from the K5.CtBP1 mice ([Fig. 4B](#F4){ref-type="fig"}, right panel), suggesting that CtBP1 over-expression in hair follicle down-regulates Dlx3 to induce the differentiation defect of the inner root sheath and hair shaft. Cross-sectional co-immunofluorescence staining of Dlx3 and CtBP1 revealed that in wildtype hair follicles the Dlx3 expression is in the inner root sheath, with CtBP1 expression mainly in the outer root sheath ([Fig. 4C](#F4){ref-type="fig"}, left panel). In K5.CtBP1 hair follicles, expression of Dlx3 was decreased, with CtBP1 expansion to the inner root sheath ([Fig. 4C](#F4){ref-type="fig"}, right panel). To evaluate the Dlx3 changes at the mRNA level, *in situ* hybridization analysis was performed. *Dlx3* mRNA was detected in the wildtype mice hair follicles ([Supplemental Figure](#SD1){ref-type="supplementary-material"}, left panel). In contrast, there was very little *Dlx3* detected in the K5.CtBP1 hair follicles ([Supplemental Figure](#SD1){ref-type="supplementary-material"}, right panel).

Next, we assayed the mRNA level of *Dlx3* in K5.CtBP1 skin by qRT-PCR and compared it to that in wildtype littermates. A significant decrease in *Dlx3* mRNA was detected in the CtBP1 transgenic skin ([Fig. 5A](#F5){ref-type="fig"}). To determine if CtBP1 plays a direct role in regulation of the *Dlx3* gene, we performed chromatin immunoprecipitation (ChIP) to see if CtBP1 is recruited to the *Dlx3* promoter in mouse keratinocytes. Mouse keratinocytes were transfected with a vector expressing CtBP1, either wildtype or the PLDLX-binding deficient mutant tagged with the FLAG epitope, and the cross-linked chromatin was immunoprecipitated with an anti-FLAG antibody. Wildtype CtBP1 bound the *Dlx3* promoter region while the PLDLX-binding deficient mutant did not ([Fig. 5B](#F5){ref-type="fig"}). This binding is limited to the promoter region, as no signal was detected with PCR amplification of the ChIP material using primers either 5′ or 3′ 2 kb to the *Dlx3* promoter ([Fig. 5B](#F5){ref-type="fig"}). Consistent with mRNA changes observed during CtBP1 knockdown, the luciferase activity of the *Dlx3* promoter decreased by 60% with CtBP1 over-expression in mouse keratinocytes ([Fig. 5C](#F5){ref-type="fig"}), indicating that CtBP1 regulates *Dlx3* transcription, at least partially, via binding to its promoter. To investigate if the CtBP1-mediated repression of *Dlx3* gene occurs in human cells, we knocked down CtBP1 in Fadu cells, a human SCC cell line exhibiting high endogenous CtBP1 ([@R5]), and assayed the Dlx3-luciferase reporter. CtBP1 knockdown increased the Dlx3-luc reporter activity ([Fig. 5D](#F5){ref-type="fig"}), suggesting that CtBP1's repressive role in *Dlx3* transcription is conserved between mouse and human.

To further study the functional consequence of CtBP1-mediated repression of the *Dlx3* gene, we examined mRNA levels of Dlx3 transcriptional targets in K5.CtBP1 skin. Gata3 and Hoxc13 are transcription factors affecting hair differentiation ([@R8]; [@R21]). Decreased Gata3 and Hoxc13 expression was detected in genetically engineered K14-Dlx3−/− mice ([@R16]). As shown in [Fig. 6A](#F6){ref-type="fig"}, CtBP1 transgene expression decreased mRNA levels of *Gata3* to 60% of that seen in control skin; small but significant changes. On the contrary, expression of *Hoxc13* was decreased to 10% of that seen in control skin by CtBP1 transgene expression ([Fig. 6A](#F6){ref-type="fig"}). [Fig. 6B](#F6){ref-type="fig"} illustrates the decrease of Gata3 and Hoxc13 expression in hair follicles of K5.CtBP1 mice.

A recent study shows Dlx3 up-regulates expression of the inner root sheath forming keratins ([@R19]). Therefore, we measured the levels of Type I inner root sheath keratin genes*. Krt25*, *Krt27*, and *Krt28*, and Type II inner root sheath keratin gene *Krt71* in wildtype and K5.CtBP1 skin. Similar to the decrease of Hoxc13 expression observed in K5.CtBP1 skin, the mRNA levels of *Krt25*, *Krt27*, and *Krt28* decreased significantly when compared to control skin ([Fig. 6C](#F6){ref-type="fig"}). The expression of *Krt71* was decreased by 4-fold as well ([Fig. 6C](#F6){ref-type="fig"}). Taken together, these findings indicate that CtBP1 over-expression triggered a down-regulation of transcription factors and hair keratins critical for the maintenance of hair follicle homeostasis.

Discussion {#S7}
==========

Epidermal E-cadherin loss, hyperproliferation and poor differentiation are caused by keratinocyte-specific CtBP1 over-expression {#S8}
--------------------------------------------------------------------------------------------------------------------------------

We and others have shown that CtBP1 expression can be re-initiated in cancers ([@R5]; [@R26]), thus we studied if pathologically induced CtBP1 over-expression perturbs skin homeostasis. Consistent with previous *in vitro* studies, we found hyperproliferation, down-regulated differentiation, and loss of E-cadherin in K5.CtBP1 mouse skin. Among potential CtBP1 targets associated with proliferation, we found down-regulation of *p21* and *Brca1*. Increased proliferation can be, but is not always, associated with reduced differentiation. Both p21 and Brca1 inhibit cell cycle progression and induce differentiation in the epidermis ([@R1]; [@R22]). Therefore, reduced p21 and Brca1 could contribute to reduced differentiation of K5.CtBP1 epidermis. We also found gradual E-cadherin loss in the transgenic epidermis and hair follicles. Keratinocyte-specific *E-cadherin* knockout mice do not show epidermal blisters but display epidermal hyperproliferation and poor differentiation in both the epidermis and hair follicles ([@R33]; [@R36]). Thus, E-cadherin loss in K5.CtBP1 transgenic mice could significantly contribute to progressive hyperplasia and poor terminal differentiation.

*Dlx3* ablation in keratinocytes has been shown to induce hyperplasia of epidermis ([@R16]). In the current study, we found CtBP1 suppresses transcription of the *Dlx3* gene, which may shift the balance between proliferation and differentiation and contribute to the overly proliferative phenotype of the K5.CtBP1 mice. In addition, the resultant down-regulation of Gata3 may further facilitate over-proliferation because *Gata3* ablation in epidermis has been shown to induce epidermal hyperplasia ([@R21]). Therefore, keratinocyte proliferation and reduced differentiation of cells in the epidermis and hair follicles appear to be critically regulated by CtBP1, as seen from the synergistic actions of p21, E-cadherin, and terminal differentiation regulators of the epidermis and hair follicles such as Dlx3 and Gata3.

CtBP1 transcriptionally represses the *DLX3* gene, a critical regulator of hair follicle differentiation {#S9}
--------------------------------------------------------------------------------------------------------

In our K5.CtBP1 transgenic model, we unexpectedly found defective hair morphogenesis caused by CtBP1 over-expression in keratinocytes. Previous studies have shown that Dlx3 is a transcriptional activator and plays a critical role in the development of epidermis, hair, bone, and placenta ([@R7]; [@R13]; [@R16]; [@R23]; [@R24]) and *Dlx3* mutations are responsible for the defects in hair, teeth and bone development called the Tricho-Dento-Osseous syndrome ([@R27]; [@R28]). Our transgenic mice displayed hair follicle differentiation abnormalities similar to the K14.Dlx3−/− mice, with smaller hair bulbs, reduced keratinized medulla and defects in the inner root sheath and hair shaft ([@R16]). While the hair loss seems regional, abnormal hair follicles were also observed where hair was retained (not shown), suggesting that mechanical triggers, such as rubbing, facilitate the hair loss. Unlike the genetically engineered mice with *Dlx3* ablation in the epidermis in which Wnt and BMP signaling are disturbed, the Wnt and BMP signaling pathways were not perturbed by CtBP1 over-expression in keratinocytes, presumably reflecting an incomplete shutdown of *Dlx3* in the K5.CtBP1 mice. The preservation of the BMP and Wnt signaling is consistent with the K5.CtBP1 mice's ability to regenerate hair despite their abnormal hair formation.

Consistent with Dlx3-mediated effects in hair follicles, keratinocyte-specific over-expression of CtBP1 caused a decrease of Gata3 and Hoxc13, transcription factors involved in hair differentiation ([@R8]; [@R34]) and Type I/II keratins. Previous study has shown that HOXC13 regulates human hair keratin gene expression ([@R17]). The inner root sheath forms its structure by obligate heterodimerization of the specified keratins. Type I inner root sheath keratin genes, *Krt25*, *Krt27*, and *Krt28*, and Type II inner root sheath keratin gene *Krt71* are specifically expressed in all three layers of the inner root sheath and support the structure ([@R30]; [@R32]). We observed that expression of these inner root sheath keratins were down-regulated by CtBP1. As a result of keratin loss, the heterodimer may be reduced, hindering the inner root sheath formation and resulting in further hair abnormality. For instance, mutations in the helix termination motif of mouse Type I inner root sheath keratin genes have been shown to impair the assembly of keratin intermediate filament ([@R32]). The ability to down-regulate both Type I and Type II keratins may further impair the inner root sheath formation.

In addition to the critical role of Dlx3 in hair follicle differentiation, ablation of *E-cadherin* in keratinocytes has been shown to induce the progressive loss of hair follicle integrity ([@R33]; [@R36]). We reason that CtBP1 contributes to the hair follicle abnormality through multiple targets including Dlx3 and E-cadherin, thus it might become more pronounced with aging. Future studies using an inducible model will help elucidate the impact of CtBP1 over-expression on epidermal and hair follicle differentiation at later stages. This model will also allow us to assess the role of CtBP1 in other pathological processes such as wound healing.

In summary, we report the CtBP1 transgenic mouse model to reveal *in vivo* CtBP1 transcriptional targets in keratinocytes and functions associated with epidermal hyperproliferation, reduced differentiation, and E-cadherin down-regulation. Further, CtBP1 has a role in hair morphogenesis; which had not been identified previously, and can only be appreciated with CtBP1 over-expression during differentiation of the hair follicle. Our data instigate future studies to determine if pathologically induced CtBP1 over-expression plays a role in skin pathogenesis in human diseases.

Methods {#S10}
=======

Generation and identification of K5.CtBP1 mice {#S11}
----------------------------------------------

All animal experiments were performed with the approval of IACUC at University of Colorado Denver. The 1.3 kb full-length wildtype human CtBP1 cDNA was inserted into the K5 expression vector ([@R14]). The K5.CtBP1 transgenic mice were generated with the B6D2 strain by microinjection of the transgene into the pronuclei of mouse embryos. Mice were genotyped by PCR analysis of tail DNA utilizing primers specific for BK5 (tctgataggcagcctgcacc) and CtBP1 (atcccagctgctgtggaagg). Throughout this study, all transgenic mice were heterozygous; all wildtype mice were littermates, and at least three independent analyses were performed for each assay, using three to five samples in each group.

Tissue histology, immunofluorescence, immunohistochemistry, western blotting, and *in situ* hybridization {#S12}
---------------------------------------------------------------------------------------------------------

Skin histology was visualized with hematoxylin and eosin (H&E) staining. Immunofluorescence, immunohistochemistry, and western blotting were performed on frozen and paraffin-embedded sections as previously described ([@R35]). Immunofluorescence and western blotting were performed using antibodies against CtBP1 (Millipore), loricrin, filaggrin (Covance), Hoxc13 (Abnova); Gata3 (Santa Cruz); E-cadherin (BD Biosciences); Dlx3 (Abcam); and Keratin 14 (Fitzgerald). The antibodies used in immunohistochemistry included CtBP1 (Millipore) and PCNA (Santa Cruz). For immunofluorescence, secondary antibodies to different species IgG were Alexa Fluor^®^ 594 (red) or 488 (green) conjugated (1:200 for all, Invitrogen). For immunohistochemistry, we used secondary biotinylated antibodies to different species IgG (1:300, Vector Labs) and developed using Vectastain ABC kit (Vector Labs). *In situ* hybridization with antisense digoxigenin-UTP-labeled RNA probes on sections of skin samples was performed as described ([@R11]).

qRT-PCR {#S13}
-------

Total RNA was isolated using TRIzol (Invitrogen) as previously described ([@R38]). One hundred nanograms of RNA from each sample were subjected to qRT-PCR (ThermoFisher). An 18S probe was used as an internal control. Each sample was examined in triplicate. The relative RNA expression levels were determined by normalizing with internal controls, the values of which were calculated using the comparative Ct method.

Cell culture and transfections {#S14}
------------------------------

Mouse keratinocytes were isolated from neonatal mouse skin as previously described ([@R12]), and cultured in PCT medium (CELLnTEC). Fadu, a human HNSCC line, was purchased from ATCC and cultured in DMEM with 10% FBS. To knock down CtBP1, cells were treated with siRNA against CtBP1 from Dharmacon using Lipofectamine 2000 (Invitrogen) for 48 hours, then harvested. Keratinocytes were treated with BrdU; cells that incorporated BrdU were stained by FITC-anti-BrdU.

Chromatin immunoprecipitation (ChIP) and luciferase reporter assay {#S15}
------------------------------------------------------------------

Keratinocytes were transfected with a CtBP1-expressing vector, either wildtype or the PLDLX-binding deficient mutant tagged with FLAG epitope. ChIP assay was performed with an anti-FLAG antibody as described previously ([@R38]). Primer sets spanning the *Dlx3* promoter were used to q-PCR-amplify the ChIP sample. The pGL4.26 *DLX3* promoter luciferase reporter plasmid was generated by cloning a PCR-amplified −286 to 0 bp fragment of the *Dlx3* promoter into the XhoI and NheI sites of pGL4.26 vector (Promega). *Dlx3* promoter--specific primers used were 5′-TATCTCGAGCCGCACAGCCAAC-3′ (forward) and 5′-AATGCTAGCGCCAGCTCCGCCC-3′ (reverse). An empty renilla luciferase vector (pGL4.79) was used for normalization. Mouse keratinocytes were co-transfected with the reporters and CtBP1-expressing plasmids for 48 hr and the luciferase activity was measured ([@R37]). Human Fadu cells were co-transfected with the reporters and siRNA to CtBP1 for 48 hr and the luciferase activity was measured ([@R37]). Scrambled siRNA or empty plasmid was used for controls.
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![Generation of K5.CtBP1 mice and phenotypes. (**A**) *CtBP1* mRNA expression in skin of wildtype mice (WT) and K5.CtBP1 transgenic mice (K1, K2, K3), and acutely wounded WT skin (wound). The mRNA level in WT skin was arbitrarily set as "1". Error bars indicate s.d. (n=3), significance was determined using Student's *t* test. \*\*, p\<0.01; \*, p\<0.05. (**B**) Hyperplasia/hyperkeratotic gross appearance of a K5.CtBP1 transgenic pup 8 days postpartum, in comparison with WT littermates. (**C**) Thin and patchy hair in K5.CtBP1 mice 3 weeks postpartum, in comparison with WT littermates. (**D**) H&E staining of WT and K5.CtBP1 tongue (top panels) and esophagus (bottom panels). Scale bar: 15 μm (top panels) and 40 μm (bottom panels).](nihms543499f1){#F1}

![Microscopic characteristics of K5.CtBP1 skin. (**A**) H&E staining of 21 day-old mice shows hyperplasia of epidermis in K5.CtBP1 skin compared with WT skin. (**B**) Western blotting of CtBP1 in WT and K5.CtBP1 skin. Keratin 14 (K14) was used as loading control. Immunohistochemistry using antibodies specific for CtBP1 (**C**) and PCNA (**D**). Scale bar: 40 μm (all panels). qRT-PCR analysis shows down-regulation of CtBP1 target genes *p21* (**E**) and *Brca1* (**F**) in K5.CtBP1 skins. p21 mRNA was decreased to 0.17±0.09 and Brca1 mRNA was decreased to 0.09±0.03 in transgenic skin. (**G**) Keratinocytes from K5.CtBP1 mice displayed an increased BrdU index. Keratin 14 (red) was used as a counterstain. Scale bar: 15 μm.](nihms543499f2){#F2}

![Aberrant differentiation in the epidermis and hair follicles of K5.CtBP1 skin. (**A**) Down-regulation of CtBP1 target gene *E-cadherin* in K5.CtBP1 skin. \*\*: p\<0.01. (**B**) Immunofluorescence staining for E-cadherin (green) demonstrates significant loss of E-cadherin in K5.CtBP1 epidermis and hair follicles. Keratin 14 (red) was used as a counterstain. Scale bar: 40 μm. (**C**) Immunofluorescence staining (green) for differentiation markers loricrin and filaggrin demonstrates loss of these proteins in K5.CtBP1 epidermis. Keratin 14 (red) was used as a counterstain. Scale bar: 40 μm. (**D**) Western blotting of loricrin and filaggrin in WT and K5.CtBP1 skin. Keratin 14 (K14) serves as a loading control. (**E**) qRT-PCR analysis of the differentiation marker genes *loricrin* and *filaggrin* in K5.CtBP1 skins. N.S., no statistical significance by Student's *t* test.](nihms543499f3){#F3}

![CtBP1 suppresses *Dlx3* gene expression in K5.CtBP1 skins. (**A**) H&E staining of WT and K5.CtBP1 hair shaft and bulb. Scale bar: 15 μm. Note the reduced hair bulbs in the transgenic mice. (**B**) Immunofluorescence staining of Dlx3 (green) demonstrates its aberrant expression pattern in K5.CtBP1 hair follicles. Keratin 14 (red) was used as a counterstain. Scale bar: 15 μm. (**C**) Cross-sectional immunofluorescence staining of Dlx3 (green) and CtBP1 (blue) demonstrates the decreased Dlx3 expression with CtBP1 expansion to the inner root sheath (IRS) in K5.CtBP1 hair follicles. ORS, outer root sheath. Keratin 14 (red) was used as a counterstain. Scale bar: 5 μm.](nihms543499f4){#F4}

![CtBP1 suppresses the *Dlx3* gene transcription. (**A**) Down-regulation of the *Dlx3* gene in K5.CtBP1 skins from 9 day-old mice. (**B**) CtBP1 binding to the *Dlx3* promoter. ChIP assay was performed in keratinocytes after transfection with FLAG-tagged CtBP1-expressing vector, either wild type or the PLDLX-binding deficient mutant. \*\* p\<0.01 vs. the PLDLX-binding deficient mutant (mt). (**C**) CtBP1 transfection represses the *Dlx3* reporter. The pGL4.26 *Dlx3* promoter reporter was generated by cloning the −286 to 0 bp fragment of the *Dlx3* promoter. (**D**) siCtBP1 increases activity of the *Dlx3* reporter. Fadu cells were transfected with scrambled siRNA (SC) or siRNA to CtBP1 (siCtBP1) and luciferase activity was measured.](nihms543499f5){#F5}

![Down-regulation of Dlx3 target genes in K5.CtBP1 skins. (**A**) WT and K5.CtBP1 skins were used for qRT-PCR*. Gata3* mRNA decreased to 0.35±0.07 and *Hoxc13* mRNA decreased to 0.11±0.06 in transgenic skin. \*\*: p\<0.01. (**B**) Immunofluorescence staining (green) of Gata3 and Hoxc13 demonstrates decreased expression in K5.CtBP1 hair follicles compared with WT follicles. Keratin 14 (red) was used as a counterstain. Scale bar: 15 μm. (**C**) WT and K5.CtBP1 skins were used for qRT-PCR *Keratin 25 (KRT25), keratin 27 (KRT27), keratin 28 (KRT28), and keratin 71 (KRT71)* mRNA expression levels. Error bars indicate s.d. (n=3), and significance was determined using Student's *t* test. \*\*: p\<0.01.](nihms543499f6){#F6}
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